Literature DB >> 3986430

Trigeminal antidromic vasodilatation and plasma extravasation in the rat: effects of acetylcholine antagonists and cholinesterase inhibitors.

R Couture, A C Cuello, J L Henry.   

Abstract

Antidromic stimulation of sensory peripheral branches of the trigeminal system (mental nerve) leads to cutaneous vasodilatation and increases vascular permeability in the rat. Antidromic vasodilatation is observed only at high intensity stimulation (10 V, 15 Hz, 0.2 or 5 ms) supporting the participation of afferent C-fibres in cutaneous dilator responses. Both antidromic vasodilatation and neurogenic plasma extravasation are significantly reduced by muscarinic antagonists suggesting that a cholinergic component may be involved in these trigeminal neurogenic responses. Neurogenic plasma extravasation remains unchanged by hexamethonium while antidromic vasodilatation is reduced. This latter effect may be merely a consequence of the dramatic fall in arterial pressure produced by the ganglion blocker. Antidromic vasodilatation is increased or unaffected by acetylcholinesterase inhibitors. On the other hand, the reduction of the plasma extravasation observed with these drugs could be due to their known ability to decrease the amount of acetylcholine released.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986430      PMCID: PMC1987139          DOI: 10.1111/j.1476-5381.1985.tb16144.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  On the transmitter responsible for antidromic vasodilatation in the rabbit's ear.

Authors:  P HOLTON; W L M PERRY
Journal:  J Physiol       Date:  1951-06       Impact factor: 5.182

2.  Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation.

Authors:  F Lembeck; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

3.  Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine.

Authors:  J C Szerb; G T Somogyi
Journal:  Nat New Biol       Date:  1973-01-24

4.  Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo.

Authors:  T L Yaksh; T M Jessell; R Gamse; A W Mudge; S E Leeman
Journal:  Nature       Date:  1980-07-10       Impact factor: 49.962

Review 5.  Substance P.

Authors:  B Pernow
Journal:  Pharmacol Rev       Date:  1983-06       Impact factor: 25.468

6.  Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation.

Authors:  P Kenins
Journal:  Neurosci Lett       Date:  1981-09-01       Impact factor: 3.046

7.  Storage and release of acetylcholine in the isolated superior cervical ganglion of the rat.

Authors:  O Sacchi; S Consolo; G Peri; I Prigioni; H Ladinsky; V Perri
Journal:  Brain Res       Date:  1978-08-11       Impact factor: 3.252

8.  Differences in thermal responses of cat trigeminal ganglion 'cold' receptors under urethane and pentobarbital anesthetization.

Authors:  H Hirata; D A Poulos; J T Molt
Journal:  Brain Res       Date:  1984-02-06       Impact factor: 3.252

9.  Acetylcholine release evoked by single or a few nerve impulses in the electric organ of Torpedo.

Authors:  Y Dunant; L Eder; L Servetiadis-Hirt
Journal:  J Physiol       Date:  1980-01       Impact factor: 5.182

10.  Inhibition of neurogenic vasodilation and plasma extravasation by substance P antagonists, somatostatin and [D-Met2, Pro5]enkephalinamide.

Authors:  F Lembeck; J Donnerer; L Barthó
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

View more
  2 in total

1.  Role of histamine in the development of neurogenic inflammation of rat oral mucosa.

Authors:  A Györfi; A Fazekas; E Pósch; F Irmes; L Rosivall
Journal:  Agents Actions       Date:  1991-03

2.  Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anaesthetic agents and an acetylcholine antagonist.

Authors:  R Couture; R Kérouac
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.